Terenius, L., and Wahlstrom, A. 1974. Inhibitor(s) of narcotic receptor binding in brain extract and cerebrospinal fluid. Acta Pharmacol. Tox. 35:Suppl. 1 Sch. Comm. 55.

Huges, J. 1975. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Research 88:295–308.

Clement Jones, V., Lowry, P. J., Rees, L. H., and Besser, G. M. 1980. Met-enkephalin circulates in human plasma. Nature. 283: 295–297.

Hambrook, J. M., Morgan, B. A., Rance, M. J., and Smith, C. F. 1976. Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 262:782–783.

Roda, L. G., De Marco, V., and Possenti, R. 1983. Stability of peripheral enkephalins. pp. 25–42 in “Degradation of endogenous opioids” S. Ehrenpreis and F. Sicuteri eds. Raven Press, New York.

Kenny, A. J., and Maroux, S. 1982. Topology of microvillar membrane hydrolase of kidney and intestine. Physiol. Rev. 62:91–128.

Amoscato, A. A., Alexander, J. W., and Babcock G. F. 1989. Surface aminopeptidase activity of human lymphocytes. J. Immunol. 142:1245–1252.

Bongiorno, L., Marini, M., Urbani, A., Ausiello, C. M., and Roda, L. G. 1993. Effect of stimulation on soluble proteolytic enzymes released by peripheral blood mononuclear cells. Int. J. Immunopharmac. 15:621–629.

Connelly, J. C., Skidgel, R. A., Schultz, W. W., Jhonson, A. R., and Erdos, E. G. 1985. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc. Natl. Acad. Sci. USA 82:8737–8741.

Drapeau, G., Chow, A., and Ward, P. E. 1991. Metabolism of bradikinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Peptides 12:631–638.

Pierart, M. E., Najdovski, T., Appelboom, T. E., and Deschodt-Lanckman, M. M. 1988. Effect of human endopeptidase 24.11 (“enkephalinase”) on IL-1-induced thymocyte proliferation activity. J. Immunol. 140:3808–3811.

Checler, F., Vincent, J. P., and Kitabgi, P. 1983. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-convertin enzyme, and other unidentified peptididases. J. Neurochem. 41:375–384.

Matsas, R., Fulcher, I. S., Kenny, A. J., and Turner, A. J. 1983. Substance P and [Leu] enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes identical with the endopeptidase of kidney microvilli. Proc. Natl. Acad. Sci. USA 80:3111–3115.

Malfroy, B., Kuang, W.-J., Seeburg, P. H., Mason, A. J., and Schofield, P. R. 1988. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Letters 229:206–210.

Caughey, G. H., Leidig, F., Viro, N. F., and Nadel, J. A. 1988. Substance P and vasoactive intestinal peptides degradation by mast cell tryptase and chynase. J. Pharmacol. Exp. Ther. 244:133–137.

Goldstein, S. M., Leong, J., and Bunnet, N.W. 1991. Human mast cell proteases hydrolyze neurotensin, kinetensin and leu5-enkephalin1. Peptides 12:995–1000.

Cochrane, D. E., Carraway, R. E., Boucher, W., and Feldberg, R. S. 1991. Rapid degradation of neurotensin by stimulated rat mast cells. Peptides 12:1187–1194.

Marini, M., Urbani, A., Bongiorno, L., and Roda, L. G. 1992. Soluble enkephalin-degrading enzymes released by lymphomic and erythroleukaemic cell lines. Neurochem. Res. 17:1155–1161.

Urbani, A., Bongiorno, L., Ausiello, C. M., Marini, M., and Roda, L. G. 1992. Role of hydrolysis in the association of leu-enkephalin to peripheral blood mononucleate cells. Int. J. Immunopharmac. 14:831–839.

Kunz, D., Buhling, F., Hutter, H.-J., Aoyagi, T., and Ansorge, S. 1993. Aminopeptidase N (CD13, EC 3.4.11.2) occurs on the surface of resting and concanavalin A-stimulated lymphocytes. Biol. Chem. Hoppe-Seyler 374:291–296.

Werfel, T., Sonntag, G., Weber, M. H., and Gotze, O. 1991. Rapid increases in the membrane of neutral endopeptidase, (Cd10) aminopeptidase N (CD13), tyrosine phosphatase (CD45) and Fc gamma-RIII (CD16) upon stimulation of human peripheral leucocytes with human C5a. J. Immunol. 147:3909–3914.

Van Hal, P. Th. W., Hopstaken-Broos, J. P. M., Wijkhuijs, J. M., Te Velde, A. A., Figdor, C. G., and Hoogsteden, H. C. 1992. Regulation of aminopeptidase-N (CD13) and Fc epsilon RIIb (CD23) expression by IL-4 depends on the stage of maturation of monocytes/macrophages. J. Immunol. 149:1395–1401.

Riemann, D., Kehlen, A., and Langner, L. 1995. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dypeptidylpeptidase IV/CD26 on human renal cell, carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines such as IL-4 and IL-13. Clin. Exp. Immunol. 100:277–283.

Chipkin, R. E., and Coffin, V. L. 1991. Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH 32615. Pharmacol. Biochem. Behav. 38:21–27.

Saksida, L. M., Galea, L. A. M., and Kavaliers, M. 1993. Antin-ociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis. Peptides 14:763–765.

Katoh, A., Nabeshima, T., Ukai, R., and Kameyama, T. 1992. Endorphins do not affect behavioral stress responses in mice. Peptides 13:737–739.

Lozzio, C. B., and Lozzio, B. B. 1975. Human chronic myelogenous leukaemia cell-line with positive Philadelphia chromosome. Blood 45:321–334.

Andersson, L. C., Jokinen, M., and Gahmberg, C. G. 1979. Induction of erythroid differentiation in the human leukaemia cell line K562. Nature 278:364–365.

Marie, J. P., Izaguirre, C. A., Civin, C. J., Mirro, J., and McCulloch, E. A. 1981. The presence within single k562 cells of erythropoietic and granulopoietic differentiation markers. Blood 58:708–711.

Cioe, L., McNab, A., Hubbell, H. R., Meo, P., Curtis, P., and Rovera, G. 1981. Differential expression of the globin genes in human leukaemia K562(s) cells induced to differentiate by hemin or butyric acid. Cancer Res. 41:237–243.

Smith, L. J., Curtiss, J. E., Messner, H., Senn, J. S., Furthmayr, H., and McCulloch, E. A. 1983. Lineage infidelity in acute leukemia. Blood 61:1138–1145.

Alder, S., Ciampi, A., and McCulloch, E. A. 1984. A kinetic and clonal analysis of heterogeneity in K562 cells. J. Cell. Physiol. 118:186–192.

van den Bergh, P., Rozing, J., and Nagelkerken, L. 1991. Two opposing modes of action of β-endorphin on lymphocyte function. Immunology 72:537–543.

Kusnecov, A. W., Husband, A. J., King, M. G., and Smith R. 1989. Modulation of mitogen-induced spleen cell proliferation and the antibody-forming cell response by beta-endorphin in vivo. Peptides 10:473–479.

van den Bergh, P., Rozing, J., and Nagelkerken, L. 1993. Identification of two moieties of β-endorphin with opposing effects on rat T-cell proliferation. Immunology 79:18–23.

Bussiere, J. L., Adler, M. W., Rogers, T. J., and Eisenstein, T. K. 1993. Cytokine reversal of morphine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 264:591–597.

Bongiorno, L., Urbani, A., Marini, M., Gilardi, E., and Roda, L. G. 1992. Hydrolysis and association of leucine-enkephalin to lymphomic and erithroleukaemic cell lines, II. Int. J. Immuno-pharmac. 17:1155–1161.

Urbani, A., Bongiorno, L., Marini, M., Zona, C., and Roda, L. G. 1994. Hydrolysis of leucine enkephalin and its association to the K562(S) erythroleukaemic cell line. Immunopharmacology 27: 119–130.